Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT03999294
Eligibility Criteria:
Inclusion Criteria:
* Over 18 years old,
* Diagnosed IBD (EC or UC) in the remission phase,
* They did not receive treatment with corticosteroids at least in the two months prior to the start of the study,
* They did not receive any extra pharmacological treatment,
* Attend the collaborating hospital center with the study, in this case, the University General Hospital of Valencia,
* Attend the schedule and schedule established for the study,
* Accept the conditions of participation in the study indicated in the signed informed consent prior to the start of the study
* \* Do not take corticosteroids during the 8 weeks between the pre-test and the post-test,
* \* Perform the pre-test before starting session 1 (in case of experimental group) or appointment 1 (in case of control group); and then the retest at the end of session 8 (in the case of an experimental group) or appointment with nursing after 8 weeks (in the case of a control group).
* \* In the case of the patients belonging to the experimental group, who at the end of the 8 weeks of treatment would have attended at least 6 of the 8 sessions established (and that, obligatorily, 2 of them were 1 and 8, where the shots were taken) sample and completed the questionnaires).
Exclusion Criteria:
The patients who were excluded from this study were those who did not meet the requirements indicated in the inclusion criteria, or who showed aversion or rejection to this type of therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
69 Years
Study:
NCT03999294
Study Brief:
Protocol Section:
NCT03999294